Total planned funding: $48,476,729
Clear active filters
Democratic Republic of the Congo
HTXD: Treatment: ARV Drugs
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Democratic Republic of the Congo | $48,476,729 |
Organizational Types
Private Contractor | $48,099,305 |
Own Agency | $351,905 |
NGO | $25,519 |
Multi-lateral Agency | $0 |
University | $0 |
FBO | $0 |
Other USG Agency | $0 |
Program Areas
Treatment | $48,476,729 |
Budget Codes
HTXD: Treatment: ARV Drugs | $48,476,729 |
Top Partner Programs
Chemonics International:
$43,516,004
Countries/Regions
Democratic Republic of the Congo
2017 | $13,616,299 |
2018 | $11,556,778 |
2020 | $18,342,927 |
Partnership for Supply Chain Management:
$4,583,301
Countries/Regions
Democratic Republic of the Congo
2013 | $1,400,000 |
2014 | $3,183,301 |
USG Aggregated Agencies:
$184,987
Countries/Regions
Democratic Republic of the Congo
2017 | $69,739 |
2018 | $115,248 |
U.S. Agency for International Development:
$142,984
Countries/Regions
Democratic Republic of the Congo
2013 | $69,400 |
2014 | $73,584 |